1.Effects of fosinopril on apoptosis and apoptosis genes in vascular smooth muscle cells
Xuguo LIANG ; Zhijun LV ;
Chinese Journal of Clinical Pharmacology and Therapeutics 2000;0(01):-
AIM : To investigate the effects of angiotensin II (AngII) in different concentrations and different action times on the rate of apoptosis and expression of apoptosis genes in vascular smooth muscle cells and the influences of fosinopril on it. METHODS : Flow cytometer was used to measure the apoptosis rate and the expression of apoptosis genes (Fas and Bcl 2) induced by AngII in different concentrations and different action times and the influence caused by fosinopril. RESULTS BZ : The rate of apoptosis and the expression of apoptosis genes were induced and increased by AngII with the increase of concentrations and action times compared with that in the control group. The expression of Fas was increased and Bcl 2 was decreased with the increase of the concentrations and action times of AngII in fosinopril group compared with that in the AngII group. CONCLUSION : The apoptosis rate and the expression of apoptosis genes are induced and increased by angiotensin II with the increase of the concentrations and the action times. Fosinopril has the regulation effect on the apoptosis rate and the expression of apoptosis genes in vascular smooth muscle cells.
2.Influence of Sevoflurane or Propofol Anesthesia Methods for The Myocardial Injury Markers of Patients with Heart Valve Replacement Surgery
Dan FAN ; Qiang LV ; Rongjuan JIANG ; Zhijun QIN ; Zhixun LAN
Journal of Kunming Medical University 2013;(9):105-109
Objective To compare the influence of whole sevoflurane inhaling and target-controlled infusion of propofol for the myocardial protective effect on patients with heart valve replacement surgery. Methods 30 adult patients who went through heart valve replacement surgery with cardiopulmonary by pass were selected, including ASA staging II-III and cardiac function classification (NYHA) II-III. All patients were randomly divided equally into sevoflurane group (Group S) and propofol group (Group P) . Patients were monitored before anesthetic induction. Group S got 1%sevoflurane (fresh gas flow 6 L/min) with concentration of the vaporizer increased from 1%to 3%with 1 minute interval during anesthetic induction. Group P got target-controlled infusion of propofol during anesthetic induction,the initial target plasma concentration was set at 0.8μg/mL,and the concentration increased 0.5 μg/mL every minute until intubation. All the patients got fentanyl 5 μg/kg and rocuronium 0.6 mg/kg, and intubation was conducted when BIS decreased lower than 60 and mean arterial pressure (MAP) <20%basic MAP. During anesthesia maintaince,patients got 0.5-2 MAC sevoflurane inhaling or target-controlled infusion of propofol 2-4μg/mL with discontinuous intravenous fentanyl and rocuronium, and maintained BIS 40-60, MAP<±20%basic MAP, central venous pressure 5-15 cm H2O. Outcome variables included demographic characteristics of patients. The following parameters were also recorded, including cardiac troponin I (cTnI), creatine kinase (CK), creatine kinase isoenzyme (CK-MB) and lactate (LAC) in before anesthetic induction (T0), aortic inbation (T1),30 minutes after aorta opening (T2), 6 hours after aorta opening (T3) and 24 hours after aorta opening (T4) . Results There was no statistical significance in demographic characteristics during peri-operation between the two groups ( > 0.05) . The pre-opertaive cTnI, CK, CK-MB and LAC were within the normal range, but increased siginicantly on T2, T3 and T4, and was more significant on T3 ( < 0.01) between two groups, and the intra-group comparison showed no difference on other time points. Conclusion When myocardial injury markers used as myocardial protection outcome variables, whole sevoflurane inhaling could not reduce the release of cTnI compared to propofol TIVA in heart valve replacement surgery.
3.Analysis of drug resistance and pathogenicity of six strains of Klebsiella pneumoniae
Chengyu Sui ; Jiazhen Wang ; Zhijun Zhang ; Lili Zhang ; Meng Lv ; Dongsheng Zhou ; Wenhui Yang
Acta Universitatis Medicinalis Anhui 2024;59(1):71-76
Objective :
To investigate the drug resistance and pathogenicity of six clinical isolates of Klebsiella pneu- moniae (Kp) ,and to provide a basis for prevention and treatment of Kp infection.
Methods :
The six strains from different hospitals were isolated ,cultured ,and identified by species-specific gene khe. Their whole genome se- quences (WGS) were obtained using next-generation sequencing technology (NGS) .Based on the WGS,the cap- sular serotypes,sequence types (ST) and drug-resistance genes of six strains were identified.The capsular sero- type genes and virulence genes were validated or identified using PCR. Broth microdilution tests were conducted to validate their drug susceptibility,and mice were challenged with Kp aerosols by MicroSprayer aerosolizer to evaluate their pathogenicity.
Results :
The six strains were all serotype K2 but belonged to four ST types ( ST14 ,ST65, ST700,and ST86) ,and collectively carried six virulence genes and 23 drug-resistance genes.All the six strains were resistant to ampicillin,but only one strain was multidrug-resistant.Four strains exhibited high mucoid charac- teristics.Five strains could cause mortality in mice,which were preliminary identified as high virulence strains.
Conclusion
For the six Kp clinical isolates from different sources,only one strain named NY 13294 is both multi- drug-resistant and highly virulent,and other four highly virulent strains are resistant to one or two types of antibiot- ics.